The chief executive of Britain's National Health Service has criticized Gwyneth Paltrow's lifestyle brand Goop and her new Netflix series, warning it carries considerable risks to health.
At an event in Oxford on Thursday, NHS chief Simon Stevens slammed Paltrow's brand for giving prominence to quacks, charlatans and cranks in promoting untested treatments like vampire facials and unusually scented candles.
Gwyneth Paltrow's brand peddles 'psychic vampire repellent,' says 'chemical sunscreen is a bad idea,' and promotes colonic irrigation and DIY coffee enema machines, he said, adding British health authorities have issued advice stating there is no scientific evidence to support such claims.
Paltrow's six-part series, The goop lab with Gwyneth Paltrow, was recently made available on Netflix in the UK.
Stevens warned about the potential of misinformation to undermine public health, citing the recent surge in measles across Britain.
Scientists have attributed the disease's rise in part to falling vaccination rates, first prompted by skepticism about the vaccine suggested in a discredited scientific study in a 1998 medical study that linked the shot to autism.
A spokeswoman for Goop said the company takes efficacy and product claims very seriously" and noted it has a legal and compliance team that works with their science and research group to vet product claims.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
